Drug recall · January 3, 2024
Sertraline Tablets recall
Why: CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, Packaged by: Legacy Pharmaceutical Packaging LLC., Earth City, MO 63045, NDC# 68645-523-54
- Lots / codes
Lot #: 222033, exp. date 08/31/2024
- Quantity
- 161,664 bottles
- Company
- Legacy Pharmaceutical Packaging LLC, Earth City, MO
- Distribution
- CA and AR
- Initiated
- December 11, 2023 · Voluntary: Firm initiated
- Classified
- December 26, 2023
- Reported
- January 3, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Sertraline
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.